Effects of GDF-15 Level in Patients with Membranous Nephropathy

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Experimed
Volume:14 Issue:1
Effects of GDF-15 Level in Patients with Membranous Nephropathy

Effects of GDF-15 Level in Patients with Membranous Nephropathy

Authors : Aıda Adıkozalova, Sebahat Usta Akgül, Erol Demir, Hayriye Şentürk Çiftçi, Fatma Savran Oğuz, Halil Yazıcı, Çiğdem Kekik Çınar

Pages : 40-45

Doi:10.26650/experimed.1403563

View : 38 | Download : 17

Publication Date : 2024-04-24

Article Type : Research Paper

Abstract :Objective: Nephrotic syndrome is the most frequent cause of membranous nephropathy (MN) in adults. Growth differentiation factor (GDF)-15 is a cytokine released under stress and associated with increased incidence of chronic kidney disease and/or decreased renal function in conditions such as diabetic nephropathy, IgA nephropathy, lupus nephritis, and primary MN. The diagnosis of MN is made by biopsy, which is an invasive procedure. A non-invasive biomarker is needed for timely and risk-free diagnosis. This study aimed to estimate the GDF-15 level in patients with MN to determine if it can be used as a noninvasive biomarker for the diagnosis of MN. Materials and Methods: The study included 88 patients with MN. Sera were obtained from peripheral blood collected from the patients. GDF-15 levels were analyzed using enzyme-linked immunosorbent assay (ELISA). Results: GDF-15 level was high in older patients that in younger patients. The glomerular filtration rate was low in patients with increased GDF-15 levels. Furthermore, a decrease in GDF-15 levels was observed in patients in remission. Conclusion: GDF-15 level may be used as a biomarker to predict the progression of MN rather than a diagnostic biomarker.
Keywords : Membranous nephropathy, GDF 15, ELISA

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.